Ripple Therapeutics, founded in 2020, is a clinical-stage biotechnology company specializing in ophthalmic therapeutics. Leveraging its patented Epidel® platform, Ripple develops controlled-release drug delivery systems that eliminate the need for frequent eye drops or injections, offering sustained therapeutic benefits for conditions such as retinal diseases, glaucoma, and opioid use disorder. The company collaborates with major pharmaceutical partners like AbbVie, Glaukos, and Bausch + Lomb to advance its pipeline of innovative treatments, focusing on improving patient compliance and outcomes in eye care and beyond.
About
Products & services in Toronto
Similar companies nearby
- Genesys Capital Partners Inc same street 200 Front St W Ste 3004, Toronto
- Toronto Symphony Orchestra 0.1 mi 500-145 Wellington St. W., Toronto
- Emkiro Inc 0.1 mi 70 University Ave, Toronto
- Steam Whistle Brewing 0.2 mi 255 Bremner Blvd, Toronto
- Atchison & Denman Court Reporting Services Limited 0.3 mi 302-155 University Ave., Toronto